Revolution Medicines, Inc. (NASDAQ:RVMD) insiders must be happy they sold stock as market cap drops to US$1.5b | Nasdaq
![Fotografía de noticias : Revolution Medicines Inc. signage is displayed on... | Noticias, Imagen de alta resolución, Marketing Fotografía de noticias : Revolution Medicines Inc. signage is displayed on... | Noticias, Imagen de alta resolución, Marketing](https://i.pinimg.com/originals/8a/d1/92/8ad192ebb498c9367005f46567c9a32f.png)
Fotografía de noticias : Revolution Medicines Inc. signage is displayed on... | Noticias, Imagen de alta resolución, Marketing
![SVB Securities Serves as Joint Bookrunner for Revolution Medicines' (Nasdaq: RVMD) $300 Million Follow-On Offering | SVB Securities SVB Securities Serves as Joint Bookrunner for Revolution Medicines' (Nasdaq: RVMD) $300 Million Follow-On Offering | SVB Securities](https://www.svbsecurities.com/wp-content/uploads/2023/03/Revolution-Logo-Deal-Announcement@2x.png)
SVB Securities Serves as Joint Bookrunner for Revolution Medicines' (Nasdaq: RVMD) $300 Million Follow-On Offering | SVB Securities
Revolution Medicines Scores With Up to $500 Million in Oncology Collaboration With Sanofi | BioSpace
![REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers](https://mma.prnewswire.com/media/944028/REVOLUTION_Medicines_logo.jpg?p=facebook)